Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Non-small Cell Lung Cancer Metastatic × Platinum × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 32 Lung Neoplasms 18 Small Cell Lung Carcinoma 16 Mesothelioma, Malignant 6 Adenocarcinoma of Lung 6 Ovarian Neoplasms 3 Stomach Neoplasms 2 Sarcoma 2 Recurrence 2 Non-squamous Non-small Cell Lung Cancer 2 NSCLC 2 Brain Neoplasms 2 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solitary Fibrous Tumor, Pleural 1 Small Cell Lung Cancer Extensive Stage 1 SCLC 1 Rhabdomyosarcoma 1 Rectal Neoplasms 1 Penile Neoplasms 1 Pelvic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Non-squamous NSCLC 1 Non-small Cell Lung Cancer Metastatic 1 Mesothelioma 1 Liposarcoma 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1

Interventions

pembrolizumab 3 Bevacizumab 3 tusamitamab ravtansine 2 Ramucirumab 2 Pemetrexed 2 Gemcitabine 2 Erlotinib Hydrochloride 2 Docetaxel 2 Carboplatin 2 1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine 2 vistusertib 1 vandetanib 1 telomerase reverse transcriptase p572Y, human 1 spartalizumab 1 sotorasib 1 olaparib 1 necitumumab 1 icotinib 1 durvalumab 1 dacomitinib 1 capivasertib 1 aumolertinib 1 Vinorelbine 1 Radiosurgery 1 Platinum 1 Paclitaxel 1 MLN 8237 1 LY3023414 1 Injections 1 GC Temporary Stopping 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05407155 2022-06-07

BETTER

Fudan University

Phase NA Unknown

Non-small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡